Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1687-1690

  Lin, Mao Song ^a   Huang, Jun Xing ^a   Zhu, JiaYi ^a   Shen, Hong Zhang ^a  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Colorectal cancer; Metastasis; Platelet count; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOCYTOSIS; TIME FACTORS;

EID: 84867696420     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12277     Document Type: Article

References (33)

1. Minagawa M, Yamamoto J, Kosuge T, et al.: Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg 2007; 142:269-276. (Pubitemid 46457054)
2. Zlobec I, Lugli A: Prognostic and predictive factors in colorectal cancer. J Clin Pathol 2008; 61:561-569. (Pubitemid 351688621)
3. Rickles FR, Falanga A: Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102:215-224.
4. Erpenbeck L, Schön MP: Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 2010; 115:3427-3436.
5. Gay LJ, Felding-Habermann B: Contribution of platelets to tumor metastasis. Nat Rev Cancer 2011; 11:123-134.
6. Yu XC, Wu SS, Lu XQ, et al.: Platelet count of peripheral blood is associated with invasion and metastasis of esophageal carcinoma. Zhejiang Da Xue Xue Bao Yi Xue Ban 2009; 38(2):170-173.
7. Dominguez I, Crippa S, Thayer SP, et al.: Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma. World J Surg 2008; 32(6):1051-1056.
8. Schwarz RE, Keny H: Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterol 2001; 48(41):1493-1498. (Pubitemid 33010454)
9. Ling FC, Vallbohmer D, Hoelscher AH, et al.: Increased platelet counts after transthoracic en bloc resection for esophageal cancer is associated with significantly improved survival. World J Surg 2010; 34(11):2628-2634.
10. Bozkurt N, Yuce K, Basaran M, Kose F, Ayhan A: Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstet Gynecol 2004; 103(1):82-85. (Pubitemid 39248471)
11. Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T: Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact CardioVasc Thorac Surg 2008; 7:613-615.
12. Hefler L, Mayerhofer K, Leibman B, et al.: Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 2000; 21(5):309-314. (Pubitemid 30666035)
13. Pedeen LM, Milman N: Diagnostic Significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 2003; 10(1):213-216.
14. Symbas NP, Townsend MF, El-Galley R, et al.: Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 2000; 86(3):203-207. (Pubitemid 30621216)
15. Trikha M, Nakada MT: Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost 2002; 28:39-44. (Pubitemid 34194871)
16. Jurasz P, Alonso-Escolano D, Radomski MW: Platelet-cancer interactions: mechanisms and pharmacology of tumor cell-induced platelet aggregation. Br J Pharmacol 2004; 143:819-826. (Pubitemid 39664840)
17. Gaorav PG, Massagué J: Platelets and metastasis revisited: a novel fatty link. J Clin Invest 2004; 114(12):1691-1693.
18. Tsuruo T, Fujita N: Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 2008; 84(6):189-198. (Pubitemid 351847103)
19. Tsuruo T, lida H, Makishima F, et al.: Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil. Cancer Chemother Pharmacol 1985; 14:30-33.
20. Falanga A: The effect of anticoagulant drugs on cancer. J Thromb Haemost 2004; 2:1263-1265.
21. Varki NM, Varki A: Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 2002; 28:53-66. (Pubitemid 34194873)
22. Amirkhosravi A, Mousa SA, Amaya M, et al.: Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 2003; 90:549-554. (Pubitemid 37138780)
23. Bakewell SJ, Nestor P, Prasad S, et al.: Platelet and osteoclast beta3 integrins are critical for bone metastasis. PNAS 2003; 100:14205-14210. (Pubitemid 37499215)
24. Bollschweiler E, Metzger R, Drebber U, et al.: Histological type of esophageal cancer might affect response to neo-adjuvant radio-chemotherapy and subsequent prognosis. Ann Oncol 2009; 20:231-238.
25. D'Angelo E, Espinosa I, Ali R, et al.: Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. Gynecol Oncol 2011; 121(2):328-333.
26. Ma J, Liu L, Tang L, et al.: Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res 2007; 13:1445-1452. (Pubitemid 46450434)
27. Eschrich S, Yang I, Bloom G, et al.: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005; 23:3526-3535.
28. Fischer CA, Kampmann M, Zlobec I, et al.: p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010; 21:1961-1966.
29. Lonsdorf AS, Krämer BF, Fahrleitner M, et al.: Engagement of αIIbß3 (GPIIb/IIIa) with αβ3 integrin mediates interaction of melanoma cells with platelets: A connection to hematogenous metastasis. J Biol Chem 2012; 287:2168-2178.
30. Suppiah R, Shaheen PE, Elson P, et al.: Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 2006; 107(8):1793-1800. (Pubitemid 44582948)
31. Taucher S, Salat A, Gnant M, et al.: Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003; 89(6):1098-1106. (Pubitemid 36798163)
32. Tsuruo T, Fujita N: Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 2008; 84(6):189-198. (Pubitemid 351847103)
33. Bomig L: Anti-metastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Semin Thromb Hemost 2007; 33(5):540-546.